Previous research has documented the ability of metformin to induce FGF21 production,37 as well as attenuate the progression of obesity, thereby ameliorating dysregulated metabolic function.23, 38, 39 On the other hand, metformin decreases FGF21 expression. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.